Environmental triggers for nerve damage in French Guiana
Part of Brain & nervous system clinical trials.
This study looks at how environmental factors may be linked to peripheral neuropathy (nerve damage) in people with diabetes or of unknown cause. It aims to find possible causes and improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must be able to complete a questionnaire.
- You must not have any objections to participating in the study.
- You must either have diabetic peripheral neuropathy or chronic idiopathic axonal polyneuropathy (nerve damage from diabetes or unknown cause), or be part of the control group without nerve damage.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well blood sugar is controlled in people with diabetes-related nerve damage, and measures how nerve signals travel through the leg. The goal is to understand whether better blood sugar control helps improve nerve function.
This study helps doctors better understand and measure sensory nerve damage (nerves that feel pain, temperature, and touch). You may qualify if you have a specific type of nerve damage caused by cancer, autoimmune disease, platinum chemotherapy, or a rare genetic condition.
This trial looks at changes in nerve function and related test results in people with chronic (long-lasting) nerve problems that are getting worse. It may help researchers better understand different causes of neuropathy and how to distinguish them.
This study looks at genetic differences in people being checked for a common type of nerve problem called distal symmetric polyneuropathy (nerve damage that usually affects the hands and feet). By understanding genetics, researchers hope to learn more about why neuropathic (nerve) pain happens and how it may differ between people.
This study looks at how the central nervous system reacts in people with type 2 diabetes who have or don't have pain from nerve damage. It aims to better understand nerve sensitivity to help improve treatment.
This study looks at how chemotherapy-related nerve damage affects daily activities like walking and standing. It includes people who currently have or have had nerve-damaging chemotherapy and are experiencing nerve pain or weakness.
Hear when a new Peripheral Neuropathies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.